IMNM

IMNM

USD

Immunome Inc. Common Stock

$15.410-0.950 (-5.807%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$16.360

Haut

$16.800

Bas

$15.060

Volume

0.74M

Fondamentaux de l'Entreprise

Capitalisation Boursière

1.3B

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

1.31M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $5.15Actuel $15.410Haut $17.87

Actualités Connexes

BusinessWire

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Immunome, Inc. (the "company") (NASDAQ:IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on Nov. 3, 2025, the Compensation Committee of

Voir plus
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BusinessWire

Immunome to Present at 2nd Annual Guggenheim Healthcare Innovation Conference

Immunome, Inc. (NASDAQ:IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Immunome management will present at the 2nd Annual Guggenheim

Voir plus
Immunome to Present at 2nd Annual Guggenheim Healthcare Innovation Conference
BusinessWire

Immunome Presents Preclinical Data Showing Proprietary TOP1i ADC Payload HC74 Overcomes Multiple Mechanisms of ADC Resistance

Immunome, Inc. (NASDAQ:IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, recently presented preclinical data showing its proprietary antibody-drug conjugate

Voir plus
Immunome Presents Preclinical Data Showing Proprietary TOP1i ADC Payload HC74 Overcomes Multiple Mechanisms of ADC Resistance

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.